Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PGNY

Progyny Inc

Feb 13 • 04:00PM ET

20.69

-0.29 -1.38 %

Healthcare • Healthcare Plans • USA • NASD

Peers: OSCR CNC MOH HUM UNH CVS CI CLOV GDRX AMWL

| Held by: IJR VTI VB IWM VBK VXF SPSM IJT IWO VTWO

Index	RUT	P/E	32.76	EPS (ttm)	0.63	Insider Own	16.13%	Shs Outstand	86.15M	Perf Week	-5.74%
Market Cap	1.78B	Forward P/E	22.06	EPS next Y	0.94	Insider Trans	0.37%	Shs Float	72.31M	Perf Month	-20.79%
Enterprise Value	1.47B	PEG	0.85	EPS next Q	0.15	Inst Own	93.09%	Short Float	3.94%	Perf Quarter	-14.04%
Income	56.57M	P/S	1.41	EPS this Y	15.61%	Inst Trans	3.56%	Short Ratio	1.96	Perf Half Y	-8.25%
Sales	1.27B	P/B	3.18	EPS next Y	42.34%	ROA	7.77%	Short Interest	2.85M	Perf YTD	-19.43%
Book/sh	6.50	P/C	5.17	EPS next 5Y	25.91%	ROE	11.37%	52W High	28.75 -28.03%	Perf Year	-5.74%
Cash/sh	4.00	P/FCF	9.22	EPS past 3/5Y	-4.58% -	ROIC	9.67%	52W Low	17.98 15.09%	Perf 3Y	-35.90%
Dividend Est.	-	EV/EBITDA	16.24	Sales past 3/5Y	32.60% 38.42%	Gross Margin	22.94%	Volatility	3.54% 3.97%	Perf 5Y	-58.95%
Dividend TTM	-	EV/Sales	1.16	EPS Y/Y TTM	8.70%	Oper. Margin	6.77%	ATR (14)	0.96	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.96	Sales Y/Y TTM	11.41%	Profit Margin	4.46%	RSI (14)	26.89	Recom	1.45
Dividend Gr. 3/5Y	- -	Current Ratio	2.96	EPS Q/Q	38.34%	SMA20	-11.52%	Beta	1.00	Target Price	30.91
Payout	0.00%	Debt/Eq	0.05	Sales Q/Q	9.32%	SMA50	-16.85%	Rel Volume	1.44	Prev Close	20.98
Employees	680	LT Debt/Eq	0.04	Earnings	Feb 26 AMC	SMA200	-9.51%	Avg Volume	1.45M	Price	20.69
IPO	Oct 25, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.92% 4.71%	Trades		Volume	2,087,652	Change	-1.38%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-20-26	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$30
Jan-08-26	Upgrade	Truist	Hold → Buy	$34
Dec-09-25	Initiated	Barclays	Overweight	$29
Nov-12-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$30
Jul-08-25	Upgrade	Leerink Partners	Market Perform → Outperform	$28
Dec-02-24	Downgrade	JP Morgan	Overweight → Neutral	$17
Nov-13-24	Downgrade	Truist	Buy → Hold	$26 → $19
Sep-19-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Aug-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$31 → $25
Aug-07-24	Downgrade	Canaccord Genuity	Buy → Hold	$37 → $24
Aug-07-24	Downgrade	BTIG Research	Buy → Neutral
Jul-16-24	Initiated	JMP Securities	Mkt Outperform	$36
May-10-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-26-24	Initiated	Leerink Partners	Outperform	$49
Jan-03-24	Initiated	Barclays	Overweight	$48
Sep-27-23	Initiated	Canaccord Genuity	Buy	$46
May-22-23	Initiated	BTIG Research	Buy	$50
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight	$44
Jan-05-23	Downgrade	SVB Leerink	Outperform → Mkt Perform	$34
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$55

Show Previous Ratings

Feb-12-26 02:46PM	Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report (GlobeNewswire)
Jan-22-26 07:20AM	Progyny price target raised to $35 from $30 at BTIG (TipRanks)
03:23AM	Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves (Insider Monkey)
Jan-20-26 03:10PM	Progyny (PGNY) Stock Is Up, What You Need To Know (StockStory)
Jan-14-26 11:35PM	3 Hyped Up Stocks That Concern Us (StockStory) -6.93%
10:07AM	Loading…
Jan-12-26 10:07AM	Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny (Zacks) +5.30%
08:00AM	Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference (GlobeNewswire)
Jan-09-26 09:15AM	Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out? (Zacks)
09:04AM	3 Medical Service Industry Stocks Set to Tackle Workforce Challenges (Zacks)
Jan-08-26 11:36AM	Progyny (PGNY) Stock Is Up, What You Need To Know (StockStory)
Dec-31-25 11:04PM	2 Reasons PGNY is Risky and 1 Stock to Buy Instead (StockStory)
Dec-23-25 09:15AM	Progyny, Inc. (PGNY) Hits Fresh High: Is There Still Room to Run? (Zacks) -5.16%
Dec-22-25 09:15AM	BrightSpring Health Services, Inc. (BTSG) Hits Fresh High: Is There Still Room to Run? (Zacks)
Dec-16-25 11:32PM	3 Healthcare Stocks We're Skeptical Of (StockStory)
Dec-15-25 12:00PM	Progyny (PGNY) Upgraded to Buy: Here's What You Should Know (Zacks)
11:31PM	Loading…
Dec-08-25 11:31PM	1 Russell 2000 Stock with Impressive Fundamentals and 2 Facing Headwinds (StockStory)
Dec-07-25 11:39PM	2 Stocks Under $50 on Our Watchlist and 1 We Find Risky (StockStory)
Nov-25-25 09:15AM	Pediatrix Medical Group, Inc. (MD) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-24-25 12:45PM	Is Progyny (PGNY) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Nov-20-25 09:23AM	New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action (GlobeNewswire)
Nov-18-25 09:15AM	Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-17-25 10:37PM	A Look Back at Health Insurance Providers Stocks' Q3 Earnings: Progyny (NASDAQ:PGNY) Vs The Rest Of The Pack (StockStory) +9.25%
Nov-14-25 11:40AM	PGNY vs. HQY: Which Stock Is the Better Value Option? (Zacks)
Nov-13-25 12:33PM	Progyny, Inc. to Present at Jefferies Global Healthcare Conference (GlobeNewswire)
12:37AM	5 Must-Read Analyst Questions From Progyny's Q3 Earnings Call (StockStory)
Nov-12-25 11:35PM	3 Inflated Stocks with Warning Signs (StockStory)
09:45AM	Carvana initiated, AT upgraded: Wall Street's top analyst calls (The Fly)
Nov-07-25 01:02PM	Why Progyny Stock Is Soaring Today (Motley Fool) +24.21%
09:21AM	PGNY Q3 Deep Dive: Product Expansion and Client Diversification Drive Momentum (StockStory)
12:08AM	Progyny Inc (PGNY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
05:20PM	Loading…
Nov-06-25 05:20PM	Progyny (PGNY) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:13PM	Progyny: Q3 Earnings Snapshot (Associated Press Finance)
04:08PM	Progyny (NASDAQ:PGNY) Reports Upbeat Q3, Stock Soars (StockStory)
04:01PM	Progyny, Inc. Announces Third Quarter 2025 Results (GlobeNewswire)
Nov-05-25 07:36AM	Earnings To Watch: Progyny Inc (PGNY) Reports Q3 2025 Result (GuruFocus.com)
Nov-04-25 10:09PM	Progyny (PGNY) Q3 Earnings: What To Expect (StockStory)
Oct-27-25 03:13AM	3 Small-Cap Stocks with Warning Signs (StockStory)
Oct-23-25 01:08PM	Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report (GlobeNewswire)
09:40AM	Are Investors Undervaluing Progyny (PGNY) Right Now? (Zacks)
Oct-22-25 04:55PM	Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks (Motley Fool)
09:28AM	Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause (GlobeNewswire)
Oct-07-25 09:40AM	Is Progyny (PGNY) Stock Undervalued Right Now? (Zacks)
09:30AM	Progyny CEO Named World Economic Forum Champion for Women's Health (GlobeNewswire)
Oct-02-25 12:04AM	3 Reasons to Avoid PGNY and 1 Stock to Buy Instead (StockStory)
Sep-26-25 08:05AM	A Healthcare Debate: Progyny vs. Hims & Hers (Motley Fool)
Sep-15-25 11:32PM	Health Insurance Providers Stocks Q2 Results: Benchmarking Progyny (NASDAQ:PGNY) (StockStory)
Sep-05-25 02:36PM	Why Progyny (PGNY) Stock Is Trading Lower Today (StockStory)
Sep-01-25 12:20PM	Surging Earnings Estimates Signal Upside for Progyny (PGNY) Stock (Zacks)
09:15AM	CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue? (Zacks)
Aug-27-25 12:32PM	Progyny (PGNY) Stock Trades Up, Here Is Why (StockStory)
Aug-21-25 12:33AM	1 Russell 2000 Stock with Impressive Fundamentals and 2 We Ignore (StockStory)
Aug-18-25 02:40PM	Progyny (PGNY) Stock Is Up, What You Need To Know (StockStory)
Aug-14-25 01:35AM	5 Must-Read Analyst Questions From Progyny's Q2 Earnings Call (StockStory)
Aug-12-25 09:00AM	URA Advances Womens Health with First-of-its-Kind Support for Pregnancy and Menopause, Bridging Gaps in Care with Personalized Biometrics and Clinical Integrations (Business Wire)
03:07AM	PGNY Q2 Deep Dive: Product Expansion and Client Diversification Drive Upbeat Guidance (StockStory)
Aug-08-25 03:38AM	Progyny Inc (PGNY) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ... (GuruFocus.com)
Aug-07-25 06:20PM	Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates (Zacks)
05:30PM	Progyny: Q2 Earnings Snapshot (Associated Press Finance)
04:48PM	Progyny (NASDAQ:PGNY) Beats Expectations in Strong Q2, Full-Year Sales Guidance is Optimistic (StockStory)
04:02PM	Progyny, Inc. Announces Second Quarter 2025 Results (GlobeNewswire)
Aug-05-25 11:16PM	Progyny Earnings: What To Look For From PGNY (StockStory)
Aug-04-25 06:15PM	Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-01-25 07:15AM	BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates (Zacks)
Jul-31-25 10:00AM	Progyny (PGNY) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-30-25 09:19AM	New Progyny Study Reveals Gap Between Perceptions and Realities in Women's Health Benefits Coverage (GlobeNewswire)
Jul-24-25 12:10PM	Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-21-25 01:15PM	Why Progyny (PGNY) Stock Is Up Today (StockStory)
Jul-18-25 12:25PM	Why Progyny (PGNY) Stock Is Falling Today (StockStory)
Jul-10-25 09:06AM	Progyny Partners with URA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause (GlobeNewswire)
09:06AM	Progyny Partners with OURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause (GlobeNewswire)
Jul-09-25 07:35AM	Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength? (Zacks)
Jul-08-25 08:09AM	Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report (GlobeNewswire) +13.15%
Jun-30-25 08:55AM	Progyny's Q1 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jun-26-25 12:33AM	1 Stock Under $50 with Exciting Potential and 2 to Question (StockStory)
Jun-24-25 02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
10:42AM	Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains? (Zacks)
10:40AM	Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength? (Zacks)
09:10AM	Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women's Health (GlobeNewswire)
08:54AM	Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength? (Zacks)
07:56AM	RGC Resources (RGCO) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
07:31AM	GeneDx Holdings (WGS) Moves 19.0% Higher: Will This Strength Last? (Zacks)
04:41AM	Strength Seen in Mobileye (MBLY): Can Its 11.6% Jump Turn into More Strength? (Zacks)
Jun-10-25 09:02AM	Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution (GlobeNewswire)
May-29-25 09:03AM	Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors (GlobeNewswire)
May-20-25 12:01AM	3 Reasons PGNY is Risky and 1 Stock to Buy Instead (StockStory)
May-18-25 11:35PM	Q1 Earnings Outperformers: Progyny (NASDAQ:PGNY) And The Rest Of The Health Insurance Providers Stocks (StockStory)
May-14-25 09:05AM	Progyny Appoints Two Renowned Women's Health Experts to Medical Advisory Board (GlobeNewswire)
May-12-25 03:58PM	Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference (GlobeNewswire)
May-09-25 11:46AM	Q1 2025 Progyny Inc Earnings Call (Thomson Reuters StreetEvents) -9.33%
03:44AM	Progyny Inc (PGNY) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions (GuruFocus.com)
May-08-25 06:55PM	Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates (Zacks)
05:55PM	Progyny: Q1 Earnings Snapshot (Associated Press Finance)
04:14PM	Progyny, Inc. Announces First Quarter 2025 Results (GlobeNewswire)
11:40AM	GDRX vs. PGNY: Which Stock Should Value Investors Buy Now? (Zacks)
09:25AM	Progyny Inc (PGNY) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
May-07-25 05:35PM	Progyny Q1 2025 Earnings Preview (Seeking Alpha)
01:10PM	Solventum Q1 Earnings Likely to Reflect Higher Costs & Expenses (Zacks)
May-06-25 01:09PM	Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates? (Zacks)
07:11AM	MCK Stock Up 24% YTD: Should You Buy, Hold or Sell Before Q4 Earnings? (Zacks)
May-05-25 02:48PM	Progyny Stock Sees RS Rating Improve To 73 (Investor's Business Daily)

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm's network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Dec 11 '25	Sale	25.50	459	11,704	46,983	Dec 15 04:12 PM
Livingston Mark S.	Officer	Dec 11 '25	Proposed Sale	25.50	459	11,704		Dec 11 02:55 PM
Swartz Allison	EVP, GC	Dec 04 '25	Sale	24.59	530	13,033	72,719	Dec 08 04:23 PM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Dec 02 '25	Sale	25.50	213	5,432	47,921	Dec 04 04:17 PM
Swartz Allison	Officer	Dec 04 '25	Proposed Sale	24.59	530	13,033		Dec 04 09:41 AM
Swartz Allison	EVP, GC	Nov 28 '25	Sale	26.87	2,398	64,434	73,657	Dec 02 04:15 PM
Livingston Mark S.	Officer	Dec 02 '25	Proposed Sale	25.50	213	5,432		Dec 02 10:24 AM
Swartz Allison	Officer	Nov 28 '25	Proposed Sale	26.87	2,398	64,434		Nov 28 09:39 AM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Nov 17 '25	Sale	25.50	21,303	543,226	48,358	Nov 19 05:03 PM
Payson Norman	Director	Nov 14 '25	Option Exercise	1.45	36,224	52,525	56,954	Nov 18 04:48 PM
Livingston Mark S.	Officer	Nov 17 '25	Proposed Sale	25.50	21,303	543,226		Nov 17 12:31 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Nov 13 '25	Buy	24.29	79,500	1,930,896	680,251	Nov 17 08:22 AM
Swartz Allison	EVP, GC	Sep 04 '25	Sale	23.53	599	14,094	77,407	Sep 05 04:39 PM
Swartz Allison	Officer	Sep 04 '25	Proposed Sale	23.53	599	14,094		Sep 04 09:35 AM
Swartz Allison	EVP, GC	Aug 28 '25	Sale	22.96	2,398	55,058	79,697	Sep 02 05:04 PM
Swartz Allison	Officer	Aug 28 '25	Proposed Sale	22.96	2,398	55,058		Aug 28 11:28 AM
GORDON KEVIN K	Director	Aug 11 '25	Sale	22.04	2,500	55,088	12,501	Aug 13 06:12 PM
GORDON KEVIN K	Director	Aug 11 '25	Proposed Sale	22.04	2,500	55,088		Aug 11 01:58 PM
Scott Cheryl	Director	Jun 11 '25	Sale	22.07	2,675	59,037	14,112	Jun 12 05:07 PM
Scott Cheryl	Director	Jun 11 '25	Proposed Sale	22.07	2,675	59,039		Jun 11 12:44 PM
Cohen Fred E	Former Director	Jun 03 '25	Proposed Sale	21.68	62,244	1,349,450		Jun 03 12:05 PM

Open in Screener

EVH

Evolent Health Inc

Feb 13 • 04:00PM ET

2.79

+0.15 5.68 %

Healthcare • Health Information Services • USA • NYSE

EVH Evolent Health Inc daily Stock Chart

Peers: UNH HUM CI CNC MOH HQY AMED UHS ACHC OPCH

| Held by: VTI IWM VB VXF VBK VTWO IWN VFVA FNDA DFAT

Index	RUT	P/E	-	EPS (ttm)	-1.57	Insider Own	8.22%	Shs Outstand	111.59M	Perf Week	-2.11%
Market Cap	311.36M	Forward P/E	9.05	EPS next Y	0.31	Insider Trans	0.11%	Shs Float	102.42M	Perf Month	-28.46%
Enterprise Value	1.25B	PEG	1.09	EPS next Q	0.05	Inst Own	112.44%	Short Float	18.75%	Perf Quarter	-37.30%
Income	-180.88M	P/S	0.15	EPS this Y	-84.33%	Inst Trans	0.15%	Short Ratio	5.51	Perf Half Y	-68.37%
Sales	2.05B	P/B	0.37	EPS next Y	379.76%	ROA	-5.17%	Short Interest	19.20M	Perf YTD	-30.25%
Book/sh	7.55	P/C	2.22	EPS next 5Y	8.33%	ROE	-13.63%	52W High	12.06 -76.88%	Perf Year	-72.02%
Cash/sh	1.26	P/FCF	-	EPS past 3/5Y	-31.56% 25.98%	ROIC	-9.51%	52W Low	2.56 9.20%	Perf 3Y	-91.43%
Dividend Est.	0.22 (7.95%)	EV/EBITDA	11.23	Sales past 3/5Y	41.18% 24.73%	Gross Margin	13.51%	Volatility	6.38% 6.68%	Perf 5Y	-85.80%
Dividend TTM	-	EV/Sales	0.61	EPS Y/Y TTM	-71.92%	Oper. Margin	0.22%	ATR (14)	0.20	Perf 10Y	-69.74%
Dividend Ex-Date	-	Quick Ratio	1.33	Sales Y/Y TTM	-16.65%	Profit Margin	-8.81%	RSI (14)	28.31	Recom	1.12
Dividend Gr. 3/5Y	- -	Current Ratio	1.33	EPS Q/Q	13.17%	SMA20	-13.88%	Beta	0.28	Target Price	9.13
Payout	-	Debt/Eq	1.29	Sales Q/Q	-22.83%	SMA50	-24.81%	Rel Volume	0.82	Prev Close	2.64
Employees	4500	LT Debt/Eq	1.26	Earnings	Feb 24 AMC	SMA200	-61.83%	Avg Volume	3.49M	Price	2.79
IPO	Jun 05, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-48.93% 2.43%	Trades		Volume	2,872,468	Change	5.68%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-13-25	Upgrade	Stephens	Equal-Weight → Overweight	$7
Nov-13-25	Initiated	BMO Capital Markets	Outperform	$7
Jan-10-25	Initiated	Needham	Buy	$15
Dec-03-24	Reiterated	BTIG Research	Buy	$36 → $29
Nov-08-24	Downgrade	Stephens	Overweight → Equal-Weight	$38 → $16
Oct-11-24	Initiated	KeyBanc Capital Markets	Overweight	$35
Aug-09-24	Upgrade	Truist	Hold → Buy	$28 → $33
Apr-22-24	Initiated	Citigroup	Buy	$40
Mar-01-24	Initiated	Oppenheimer	Outperform	$45
Jan-03-24	Initiated	Barclays	Overweight	$39
Dec-06-23	Initiated	JMP Securities	Mkt Outperform	$37
Oct-16-23	Initiated	UBS	Buy	$46
Apr-12-23	Initiated	Stephens	Overweight	$40
Nov-01-22	Initiated	Truist	Hold	$33
Jul-29-22	Initiated	RBC Capital Mkts	Outperform	$40
Mar-30-22	Initiated	Guggenheim	Buy	$43
Nov-18-21	Upgrade	JP Morgan	Neutral → Overweight	$26 → $37
Apr-29-21	Resumed	JP Morgan	Neutral	$23
Jan-07-21	Initiated	BTIG Research	Buy	$20
Jul-06-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight

Show Previous Ratings

Feb-11-26 11:36PM	3 Value Stocks We Find Risky (StockStory)
Feb-09-26 09:14AM	Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion (Insider Monkey)
Feb-05-26 07:45AM	Omnicell (OMCL) Q4 Earnings Lag Estimates (Zacks) -5.56%
Feb-04-26 11:02AM	Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026 (PR Newswire)
Jan-02-26 04:15PM	Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 (PR Newswire)
08:48AM	Loading…
Dec-23-25 08:48AM	Is the Options Market Predicting a Spike in Evolent Health Stock? (Zacks)
Dec-22-25 09:53AM	Evolent Health (EVH) Sells ACO Unit, Strengthens Balance Sheet (Insider Monkey)
Dec-15-25 11:11PM	Evolent Health (EVH) Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in Medicare/Medicaid Membership (Insider Monkey)
Nov-20-25 01:27AM	Evolent Health, American Oncology Network Partner to Streamline Cancer Care (Insider Monkey)
Nov-19-25 04:05PM	Why Evolent Health (EVH) Shares Are Sliding Today (StockStory) -11.50%
Nov-17-25 11:03PM	3 Reasons to Sell EVH and 1 Stock to Buy Instead (StockStory) -7.42%
Nov-13-25 10:32PM	Healthcare Technology for Providers Stocks Q3 In Review: Evolent Health (NYSE:EVH) Vs Peers (StockStory) -6.52%
12:36AM	The Top 5 Analyst Questions From Evolent Health's Q3 Earnings Call (StockStory)
Nov-12-25 03:20PM	Why Evolent Health (EVH) Shares Are Sliding Today (StockStory) -11.71%
Nov-07-25 06:30PM	EVH Q3 Deep Dive: Contract Wins and Industry Uncertainty Shape Outlook (StockStory) -17.33%
12:11AM	Loading…
12:11AM	Evolent Health Inc (EVH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market ... (GuruFocus.com)
Nov-06-25 08:30PM	Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics (Zacks) -5.51%
06:35PM	Evolent Health (EVH) Misses Q3 Earnings Estimates (Zacks)
05:34PM	Evolent Health: Q3 Earnings Snapshot (Associated Press Finance)
05:17PM	Evolent Health (NYSE:EVH) Beats Q3 Sales Expectations, Stock Jumps 14.8% (StockStory)
04:12PM	Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden (PR Newswire)
04:10PM	Evolent Announces Third Quarter 2025 Results (PR Newswire)
Nov-04-25 10:16PM	Evolent Health (EVH) Reports Earnings Tomorrow: What To Expect (StockStory)
Nov-03-25 05:35PM	Inspire Medical Systems (INSP) Tops Q3 Earnings and Revenue Estimates (Zacks)
Oct-09-25 08:30AM	Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025 (PR Newswire)
Sep-26-25 12:05AM	3 Reasons EVH is Risky and 1 Stock to Buy Instead (StockStory)
Sep-25-25 12:41PM	Why Evolent Health (EVH) Shares Are Sliding Today (StockStory) -7.18%
Sep-24-25 01:38PM	Privia Health Acquires Evolent's ACO Business To Boost Value-Based Care (Benzinga) +14.54%
12:00PM	Evolent Health (EVH) Stock Trades Up, Here Is Why (StockStory)
05:14AM	Privia acquires Evolents value-based primary care unit for $100M (Healthcare Dive)
04:10PM	Loading…
Sep-23-25 04:10PM	Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners (PR Newswire)
Sep-17-25 12:12PM	CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention? (Zacks)
Sep-10-25 11:31PM	Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Evolent Health (NYSE:EVH) (StockStory) -8.01%
Aug-19-25 07:00AM	Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock (PR Newswire)
Aug-18-25 04:05PM	Evolent Health, Inc. Announces Proposed Offering of $140.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock (PR Newswire)
Aug-14-25 01:42AM	5 Insightful Analyst Questions From Evolent Health's Q2 Earnings Call (StockStory)
Aug-11-25 09:38AM	EVH Q2 Deep Dive: Revenue Falls Short, Guidance Cut as Margin Initiatives Continue (StockStory)
Aug-08-25 12:21PM	Why Evolent Health (EVH) Stock Is Nosediving (StockStory) -7.12%
05:10AM	Evolent Health (NYSE:EVH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops (StockStory)
03:41AM	Evolent Health Inc (EVH) Q2 2025 Earnings Call Highlights: Strong Partnerships and Revenue ... (GuruFocus.com)
Aug-07-25 08:00PM	Evolent Health (EVH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
06:15PM	Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:16PM	Evolent Health: Q2 Earnings Snapshot (Associated Press Finance)
04:10PM	Evolent Announces Second Quarter 2025 Results (PR Newswire)
Aug-05-25 11:16PM	Evolent Health (EVH) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-31-25 05:40PM	iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
10:00AM	Earnings Preview: Evolent Health (EVH) Q2 Earnings Expected to Decline (Zacks)
Jul-29-25 08:55AM	NYSE Content Advisory: Pre-market update + Wall Street anticipates Fed's next move (PR Newswire)
Jul-23-25 10:03AM	Ashley Snyder Joins Medical Home Network as Chief Development Officer to Lead Partnership Efforts (PR Newswire)
Jul-18-25 03:10PM	Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know (StockStory) -15.44%
Jul-14-25 08:00AM	Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 (PR Newswire)
Jul-09-25 08:00AM	Evolent announces key appointments to leadership team (PR Newswire)
Jul-07-25 10:18AM	The Top 5 Analyst Questions From Evolent Health's Q1 Earnings Call (StockStory)
Jun-30-25 12:02AM	3 Reasons to Avoid EVH and 1 Stock to Buy Instead (StockStory)
Jun-23-25 08:35AM	Evolent Health (EVH) Stock Jumps 6.9%: Will It Continue to Soar? (Zacks) +13.51%
Jun-20-25 06:30AM	Evolent reiterates Q2 and full year guidance for Adjusted EBITDA (PR Newswire) +6.94%
Jun-10-25 07:48AM	EVH Q1 Earnings Call: Oncology Navigation Launch and AI Automation Drive Strategic Focus (StockStory) +5.78%
May-27-25 02:28PM	Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know (StockStory) +6.80%
May-21-25 11:34PM	Reflecting On Healthcare Technology for Providers Stocks' Q1 Earnings: Evolent Health (NYSE:EVH) (StockStory) -8.78% -8.00%
May-09-25 02:00PM	Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) -16.05%
08:13AM	Q1 2025 Evolent Health Inc Earnings Call (Thomson Reuters StreetEvents)
03:46AM	Evolent Health Inc (EVH) Q1 2025 Earnings Call Highlights: Strong Start with New Agreements and ... (GuruFocus.com)
May-08-25 06:35PM	Evolent Health (EVH) Q1 Earnings Lag Estimates (Zacks)
05:33PM	Evolent Health: Q1 Earnings Snapshot (Associated Press Finance)
04:10PM	Evolent Announces First Quarter 2025 Results (PR Newswire)
May-07-25 05:20PM	Evolent Health Q1 2025 Earnings Preview (Seeking Alpha)
10:19AM	What to Expect from Evolent Health Inc (EVH) Q1 2025 Earnings (GuruFocus.com)
09:55AM	Wall Street Analysts Believe Evolent Health (EVH) Could Rally 53.33%: Here's is How to Trade (Zacks)
May-05-25 12:37AM	1 Unprofitable Stock Worth Investigating and 2 to Question (StockStory)
Apr-29-25 05:06AM	Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks (StockStory) +5.35%
Apr-28-25 05:04AM	Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks (StockStory)
Apr-22-25 06:30AM	Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors (PR Newswire)
Apr-15-25 09:00AM	Evolent program achieves 20% reduction in use of low-value oncology regimens (PR Newswire) -5.11%
Apr-11-25 01:15PM	Buy Certara After The FDA Announcement (Seeking Alpha)
12:30AM	Embark Small Cap Equity Fund Q4 2024 Commentary (Seeking Alpha)
Apr-10-25 05:00PM	Evolent To Release First Quarter 2025 Financial Results on Thursday, May 8, 2025 (PR Newswire)
Apr-01-25 10:05AM	Evolent Health, Inc. (EVH): Among Stocks Insiders Were Buying In Q1 2025 (Insider Monkey)
Mar-28-25 04:51PM	Is Evolent Health, Inc. (EVH) About to Explode? (Insider Monkey)
Mar-25-25 10:45AM	Allspring Small Company Growth Fund Q4 2024 Commentary (SeekingAlpha)
07:39AM	Here's What Challenged Evolent Health (EVH) Despite Strong Revenue Growth (InsiderMonkey)
Mar-21-25 04:30AM	Lazard US Small Cap Equity Select Portfolio Q4 2024 Commentary (SeekingAlpha)
Mar-20-25 12:00PM	Lazard US Equity Concentrated Portfolio Q4 2024 Commentary (SeekingAlpha)
Mar-18-25 08:17AM	Evolent Health (EVH): Among Stocks Insiders Are Buying In March (Insider Monkey)
Mar-14-25 05:02AM	Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR) (StockStory)
Mar-11-25 05:30AM	Define Ventures Appoints Carolyn Magill as Venture Partner (PR Newswire)
Mar-07-25 04:00AM	3 Reasons to Sell EVH and 1 Stock to Buy Instead (StockStory)
Feb-21-25 07:15AM	Evolent Health (EVH) Q4 2024 Earnings Call Transcript (Motley Fool)
02:16AM	Evolent Health Inc (EVH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Oncology ... (GuruFocus.com)
Feb-20-25 06:00PM	Evolent Health (EVH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:43PM	Evolent Health (NYSE:EVH) Misses Q4 Sales Targets (StockStory)
05:40PM	Evolent Health (EVH) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:41PM	Evolent Health: Q4 Earnings Snapshot (Associated Press Finance)
04:10PM	Evolent Announces Fourth Quarter and Full Year 2024 Results (PR Newswire)
09:13AM	Evolent Health Inc (EVH) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-19-25 08:01AM	Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-17-25 09:16AM	Evolent Health (EVH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Feb-13-25 10:00AM	Earnings Preview: Evolent Health (EVH) Q4 Earnings Expected to Decline (Zacks)
Feb-04-25 07:00AM	Evolent Health Announces Changes to Board of Directors (PR Newswire)
Jan-27-25 05:00PM	Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025 (PR Newswire)
Jan-23-25 07:15AM	Evolent Health price target lowered to $20 from $29 at BTIG (TipRanks)

Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Springstubb Brendan B	Director	Nov 18 '25	Buy	3.82	10,000	38,199	58,821	Nov 19 04:23 PM
Holder Diane	Director	Mar 06 '25	Buy	9.33	2,735	25,518	70,584	Mar 10 08:20 AM
McCarthy Daniel Joseph	PRESIDENT	Mar 06 '25	Buy	9.01	11,040	99,470	389,004	Mar 10 08:18 AM
Jelinek Richard M	Director	Mar 07 '25	Buy	9.12	30,000	273,750	15,000	Mar 10 08:16 AM
GRUA PETER J	Director	Mar 06 '25	Buy	9.01	11,040	99,470	18,749	Mar 10 08:13 AM
Blackley Seth	Chief Executive Officer	Mar 06 '25	Buy	9.01	55,225	497,577	762,217	Mar 10 08:11 AM
Springstubb Brendan B	Director	Mar 07 '25	Buy	9.27	15,000	139,050	26,842	Mar 10 08:10 AM
Glass Russell Monroe	Director	Mar 06 '25	Buy	9.27	5,400	50,058	14,272	Mar 10 08:07 AM
KECK KIM	Director	Mar 07 '25	Buy	9.44	10,540	99,498	39,522	Mar 10 08:04 AM
Barbarosh Craig A.	Director	Mar 06 '25	Buy	8.81	2,000	17,620	31,956	Mar 10 08:02 AM
Springstubb Brendan B	Director	Mar 04 '25	Buy	8.75	5,000	43,750	11,842	Mar 05 05:28 PM
DUFFY MARY BRIDGET	Director	Feb 25 '25	Proposed Sale	10.27	9,151	93,938		Feb 25 04:47 PM

PGNY

Progyny Inc

EVH

Evolent Health Inc

Upgrade your FINVIZ experience